世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035466

乗り物酔い治療薬の世界市場(2023-2027)

TechNavio

Global Motion Sickness Drugs Market 2023-2027

発刊日 2023/05/09

言語英語

体裁PDF/160ページ

ライセンス/価格160ページ

0000035466

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

乗り物酔い治療薬市場は、2022年から2027年の間に1億3,649万米ドル成長すると予測されており、予測期間中にCAGRは4.43%で加速します。乗り物酔い治療薬市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。この市場は、市販薬の入手可能性、複数の剤形での乗り物酔い治療薬の入手可能性、そして世界中で成長する旅行と観光によって牽引されています。

乗り物酔い治療薬市場は次のように分類されます。

  • 製品別
    ➣ 抗ヒスタミン薬
    ➣ 抗コリン薬
  • 流通チャネル別
    ➣ オフライン
    ➣ オンライン児
  • 地域別
    ➣ 北アメリカ
    ➣ ヨーロッパ
    ➣ アジア
    ➣ 世界のその他の地域

この調査は、吐き気を引き起こす情報技術の出現が、今後数年間の乗り物酔い治療薬市場の成長を促進する主な理由の1つであることを特定しています。また、オンラインチャネルの浸透の増加と心身症に関する研究の増加により、市場での大きな需要が見込まれるでしょう。

乗り物酔い治療薬市場に関するレポートは、次の分野をカバーしています。

  • 乗り物酔い治療薬市場の規模
  • 乗り物酔い治療薬市場の予測
  • 乗り物酔い治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、乗り物酔い治療薬市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ Amneal Pharmaceuticals Inc.
    ➣ Baxter International Inc.
    ➣ CVS Health Corp.
    ➣ GlaxoSmithKline Plc
    ➣ Lupin Ltd.
    ➣ Myungmoon Pharm Co. Ltd.
    ➣ Novartis AG
    ➣ Perrigo Co. Plc
    ➣ Prestige Consumer Healthcare Inc.
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Tivic Health Systems Inc.
    ➣ Viatris Inc.
    ➣ WellSpring Pharmaceutical Corp.
    ➣ Zydus Lifesciences Ltd.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global motion sickness drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global motion sickness drugs market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Antihistamines - Market size and forecast 2022-2027
Exhibit 34: Chart on Antihistamines - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Antihistamines - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Antihistamines - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antihistamines - Year-over-year growth 2022-2027 (%)
6.4 Anticholinergics - Market size and forecast 2022-2027
Exhibit 38: Chart on Anticholinergics - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Anticholinergics - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Anticholinergics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Anticholinergics - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ million)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 Amneal Pharmaceuticals Inc.
Exhibit 112: Amneal Pharmaceuticals Inc. - Overview
Exhibit 113: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 114: Amneal Pharmaceuticals Inc. - Key news
Exhibit 115: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 116: Amneal Pharmaceuticals Inc. - Segment focus
12.5 Baxter International Inc.
Exhibit 117: Baxter International Inc. - Overview
Exhibit 118: Baxter International Inc. - Business segments
Exhibit 119: Baxter International Inc. - Key news
Exhibit 120: Baxter International Inc. - Key offerings
Exhibit 121: Baxter International Inc. - Segment focus
12.6 CVS Health Corp.
Exhibit 122: CVS Health Corp. - Overview
Exhibit 123: CVS Health Corp. - Business segments
Exhibit 124: CVS Health Corp. - Key news
Exhibit 125: CVS Health Corp. - Key offerings
Exhibit 126: CVS Health Corp. - Segment focus
12.7 GlaxoSmithKline Plc
Exhibit 127: GlaxoSmithKline Plc - Overview
Exhibit 128: GlaxoSmithKline Plc - Business segments
Exhibit 129: GlaxoSmithKline Plc - Key news
Exhibit 130: GlaxoSmithKline Plc - Key offerings
Exhibit 131: GlaxoSmithKline Plc - Segment focus
12.8 Lupin Ltd.
Exhibit 132: Lupin Ltd. - Overview
Exhibit 133: Lupin Ltd. - Product / Service
Exhibit 134: Lupin Ltd. - Key news
Exhibit 135: Lupin Ltd. - Key offerings
12.9 Myungmoon Pharm Co. Ltd.
Exhibit 136: Myungmoon Pharm Co. Ltd. - Overview
Exhibit 137: Myungmoon Pharm Co. Ltd. - Product / Service
Exhibit 138: Myungmoon Pharm Co. Ltd. - Key offerings
12.10 Novartis AG
Exhibit 139: Novartis AG - Overview
Exhibit 140: Novartis AG - Business segments
Exhibit 141: Novartis AG - Key offerings
Exhibit 142: Novartis AG - Segment focus
12.11 Perrigo Co. Plc
Exhibit 143: Perrigo Co. Plc - Overview
Exhibit 144: Perrigo Co. Plc - Business segments
Exhibit 145: Perrigo Co. Plc - Key news
Exhibit 146: Perrigo Co. Plc - Key offerings
Exhibit 147: Perrigo Co. Plc - Segment focus
12.12 Prestige Consumer Healthcare Inc.
Exhibit 148: Prestige Consumer Healthcare Inc. - Overview
Exhibit 149: Prestige Consumer Healthcare Inc. - Business segments
Exhibit 150: Prestige Consumer Healthcare Inc. - Key offerings
Exhibit 151: Prestige Consumer Healthcare Inc. - Segment focus
12.13 Sun Pharmaceutical Industries Ltd.
Exhibit 152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 154: Sun Pharmaceutical Industries Ltd. - Key offerings
12.14 Tivic Health Systems Inc.
Exhibit 155: Tivic Health Systems Inc. - Overview
Exhibit 156: Tivic Health Systems Inc. - Product / Service
Exhibit 157: Tivic Health Systems Inc. - Key offerings
12.15 Viatris Inc.
Exhibit 158: Viatris Inc. - Overview
Exhibit 159: Viatris Inc. - Business segments
Exhibit 160: Viatris Inc. - Key news
Exhibit 161: Viatris Inc. - Key offerings
Exhibit 162: Viatris Inc. - Segment focus
12.16 WellSpring Pharmaceutical Corp.
Exhibit 163: WellSpring Pharmaceutical Corp. - Overview
Exhibit 164: WellSpring Pharmaceutical Corp. - Product / Service
Exhibit 165: WellSpring Pharmaceutical Corp. - Key offerings
12.17 Zydus Lifesciences Ltd.
Exhibit 166: Zydus Lifesciences Ltd. - Overview
Exhibit 167: Zydus Lifesciences Ltd. - Business segments
Exhibit 168: Zydus Lifesciences Ltd. - Key offerings
Exhibit 169: Zydus Lifesciences Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global motion sickness drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Antihistamines - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Antihistamines - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Antihistamines - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antihistamines - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Anticholinergics - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Anticholinergics - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Anticholinergics - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Anticholinergics - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Distribution Channel ($ million)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories - Overview
Exhibits108: Abbott Laboratories - Business segments
Exhibits109: Abbott Laboratories - Key news
Exhibits110: Abbott Laboratories - Key offerings
Exhibits111: Abbott Laboratories - Segment focus
Exhibits112: Amneal Pharmaceuticals Inc. - Overview
Exhibits113: Amneal Pharmaceuticals Inc. - Business segments
Exhibits114: Amneal Pharmaceuticals Inc. - Key news
Exhibits115: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits116: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits117: Baxter International Inc. - Overview
Exhibits118: Baxter International Inc. - Business segments
Exhibits119: Baxter International Inc. - Key news
Exhibits120: Baxter International Inc. - Key offerings
Exhibits121: Baxter International Inc. - Segment focus
Exhibits122: CVS Health Corp. - Overview
Exhibits123: CVS Health Corp. - Business segments
Exhibits124: CVS Health Corp. - Key news
Exhibits125: CVS Health Corp. - Key offerings
Exhibits126: CVS Health Corp. - Segment focus
Exhibits127: GlaxoSmithKline Plc - Overview
Exhibits128: GlaxoSmithKline Plc - Business segments
Exhibits129: GlaxoSmithKline Plc - Key news
Exhibits130: GlaxoSmithKline Plc - Key offerings
Exhibits131: GlaxoSmithKline Plc - Segment focus
Exhibits132: Lupin Ltd. - Overview
Exhibits133: Lupin Ltd. - Product / Service
Exhibits134: Lupin Ltd. - Key news
Exhibits135: Lupin Ltd. - Key offerings
Exhibits136: Myungmoon Pharm Co. Ltd. - Overview
Exhibits137: Myungmoon Pharm Co. Ltd. - Product / Service
Exhibits138: Myungmoon Pharm Co. Ltd. - Key offerings
Exhibits139: Novartis AG - Overview
Exhibits140: Novartis AG - Business segments
Exhibits141: Novartis AG - Key offerings
Exhibits142: Novartis AG - Segment focus
Exhibits143: Perrigo Co. Plc - Overview
Exhibits144: Perrigo Co. Plc - Business segments
Exhibits145: Perrigo Co. Plc - Key news
Exhibits146: Perrigo Co. Plc - Key offerings
Exhibits147: Perrigo Co. Plc - Segment focus
Exhibits148: Prestige Consumer Healthcare Inc. - Overview
Exhibits149: Prestige Consumer Healthcare Inc. - Business segments
Exhibits150: Prestige Consumer Healthcare Inc. - Key offerings
Exhibits151: Prestige Consumer Healthcare Inc. - Segment focus
Exhibits152: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits153: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits154: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits155: Tivic Health Systems Inc. - Overview
Exhibits156: Tivic Health Systems Inc. - Product / Service
Exhibits157: Tivic Health Systems Inc. - Key offerings
Exhibits158: Viatris Inc. - Overview
Exhibits159: Viatris Inc. - Business segments
Exhibits160: Viatris Inc. - Key news
Exhibits161: Viatris Inc. - Key offerings
Exhibits162: Viatris Inc. - Segment focus
Exhibits163: WellSpring Pharmaceutical Corp. - Overview
Exhibits164: WellSpring Pharmaceutical Corp. - Product / Service
Exhibits165: WellSpring Pharmaceutical Corp. - Key offerings
Exhibits166: Zydus Lifesciences Ltd. - Overview
Exhibits167: Zydus Lifesciences Ltd. - Business segments
Exhibits168: Zydus Lifesciences Ltd. - Key offerings
Exhibits169: Zydus Lifesciences Ltd. - Segment focus
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations

この商品のレポートナンバー

0000035466

TOP